Marie Wetzel

428 total citations
8 papers, 366 citations indexed

About

Marie Wetzel is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Marie Wetzel has authored 8 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Marie Wetzel's work include Hormonal Regulation and Hypertension (8 papers), Estrogen and related hormone effects (8 papers) and Organic Chemistry Cycloaddition Reactions (2 papers). Marie Wetzel is often cited by papers focused on Hormonal Regulation and Hypertension (8 papers), Estrogen and related hormone effects (8 papers) and Organic Chemistry Cycloaddition Reactions (2 papers). Marie Wetzel collaborates with scholars based in Germany and Switzerland. Marie Wetzel's co-authors include Sandrine Marchais‐Oberwinkler, Rolf W. Hartmann, Jerzy Adamski, Gabriele Möller, Kuiying Xu, Ruth Werth, Martin Frotscher, Claudia Henn, Matthias Negri and Alexander Oster and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Marie Wetzel

8 papers receiving 361 citations

Peers

Marie Wetzel

GENET

EDM

MB

OC

PHARM

Alexander Oster Germany

Ruth Werth Germany

Ivonne Heuze Mexico

Emmanuel Bey Germany

Bolette Husman Sweden

Petra Brožič Slovenia

Jong M. Wasvary Switzerland

Patricia Kruchten Germany

Tiphaine Huet France

Martin Perreault Canada

Alexander Oster Germany

Marie Wetzel

345 ×1.6

GENET

325 ×1.5

EDM

172 ×1.4

MB

150 ×2.3

OC

65 ×1.4

PHARM

Citations per year, relative to Marie Wetzel Marie Wetzel (= 1×) peers Alexander Oster

Countries citing papers authored by Marie Wetzel

Since Specialization

Citations

This map shows the geographic impact of Marie Wetzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Wetzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Wetzel more than expected).

Fields of papers citing papers by Marie Wetzel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Wetzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Wetzel. The network helps show where Marie Wetzel may publish in the future.

Co-authorship network of co-authors of Marie Wetzel

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Wetzel. A scholar is included among the top collaborators of Marie Wetzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Wetzel. Marie Wetzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Marchais‐Oberwinkler, Sandrine, Kuiying Xu, Marie Wetzel, et al.. (2012). Structural Optimization of 2,5-Thiophene Amides as Highly Potent and Selective 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors for the Treatment of Osteoporosis. Journal of Medicinal Chemistry. 56(1). 167–181. 24 indexed citations

2.

Wetzel, Marie, Sandrine Marchais‐Oberwinkler, Enrico Perspicace, et al.. (2011). Introduction of an Electron Withdrawing Group on the Hydroxyphenylnaphthol Scaffold Improves the Potency of 17β-Hydroxysteroid Dehydrogenase Type 2 (17β-HSD2) Inhibitors. Journal of Medicinal Chemistry. 54(21). 7547–7557. 39 indexed citations

3.

Xu, Kuiying, Marie Wetzel, Rolf W. Hartmann, & Sandrine Marchais‐Oberwinkler. (2011). Synthesis and Biological Evaluation of Spiro-δ-lactones as Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 2 (17β-HSD2). Letters in Drug Design & Discovery. 8(5). 406–421. 12 indexed citations

4.

Wetzel, Marie, et al.. (2011). Discovery of a new class of bicyclic substituted hydroxyphenylmethanones as 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitors for the treatment of osteoporosis. European Journal of Medicinal Chemistry. 47(1). 1–17. 23 indexed citations

5.

Xu, Kuiying, Yaseen A. Al‐Soud, Marie Wetzel, Rolf W. Hartmann, & Sandrine Marchais‐Oberwinkler. (2011). Triazole ring-opening leads to the discovery of potent nonsteroidal 17β-hydroxysteroid dehydrogenase type 2 inhibitors. European Journal of Medicinal Chemistry. 46(12). 5978–5990. 13 indexed citations

6.

Wetzel, Marie, Sandrine Marchais‐Oberwinkler, & Rolf W. Hartmann. (2010). 17β-HSD2 inhibitors for the treatment of osteoporosis: Identification of a promising scaffold. Bioorganic & Medicinal Chemistry. 19(2). 807–815. 36 indexed citations

7.

Marchais‐Oberwinkler, Sandrine, Claudia Henn, Gabriele Möller, et al.. (2010). 17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development. The Journal of Steroid Biochemistry and Molecular Biology. 125(1-2). 66–82. 170 indexed citations

8.

Marchais‐Oberwinkler, Sandrine, Marie Wetzel, Erika Ziegler, et al.. (2010). New Drug-Like Hydroxyphenylnaphthol Steroidomimetics As Potent and Selective 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Estrogen-Dependent Diseases. Journal of Medicinal Chemistry. 54(2). 534–547. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact